Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    Open Studies | "Blindness"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Blindness"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Melatonin for Circadian Sleep Disorders in the Blind
Conditions: Insomnia;   Blindness;   Daytime Sleepiness
Interventions: Drug: Melatonin;   Behavioral: Regular Sleep Schedule;   Behavioral: Light
2 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
3 Unknown  Functional Neuroimaging of Cortical Plasticity in the Human Visual System
Conditions: Stroke;   Blindness;   Vision
Intervention:
4 Unknown  Neuroplasticity in Blind Subjects After Repetitive Tactile Stimulation
Condition: Blindness
Intervention: Other: Tactile Training
5 Unknown  Do Blue-Blocking Lenses Block Blue Colour From Our Lives?
Condition: Blindness
Intervention: Procedure: cataract surgery
6 Recruiting Blind Child Melatonin Treatment Study
Condition: Blindness
Interventions: Dietary Supplement: Melatonin;   Biological: Melatonin
7 Unknown  Melatonin Studies of Totally Blind Children
Conditions: Sleep Disorder;   Blindness
Intervention: Drug: Melatonin
8 Recruiting Evaluating Color Perception Under LED Red/Green and Green Dominant Light
Condition: Color Blindness, Acquired
Interventions: Device: White LED Flashlight;   Device: Red/Green Green Dominant LED Flashlight
9 Not yet recruiting Prematurity as Predictor of Children's Cardiovascular-renal Health
Conditions: Endothelial Dysfunction;   Sublingual Capillary Glycocalyx and Density;   Visual Disturbances and Blindness;   Ventricular Dysfunction, Left;   Renal Impairment
Intervention:
10 Recruiting Nitisinone for Type 1B Oculocutaneous Albinism
Conditions: Albinism;   Vision Loss
Intervention: Drug: Nitisinone (NTBC)
11 Unknown  Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
Condition: Age-Related Neovascular Macular Degeneration
Interventions: Drug: bevacizumab;   Drug: ranibizumab
12 Not yet recruiting Investigating Optical and Neural Causes of Vision Loss
Condition: Macular Degeneration
Intervention:
13 Recruiting Gene Therapy for Blindness Caused by Choroideremia
Condition: Choroideremia
Intervention: Drug: rAAV2.REP1
14 Unknown  Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
Condition: Glaucoma
Interventions: Device: portable CCTV;   Device: Telescopes, telemicroscopes and microscopes;   Device: Absorptive filters
15 Recruiting Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Condition: Vitamin A Deficiency
Intervention:
16 Recruiting Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit
Condition: Vitamin A Deficiency
Interventions: Dietary Supplement: Vitamin A (<3-day postpartum);   Dietary Supplement: Vitamin A (6 wk postpartum);   Dietary Supplement: Vitamin A (<3-day and 6 wk postpartum);   Dietary Supplement: Placebo
17 Not yet recruiting Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection
Condition: Vitamin A Deficiency
Intervention: Dietary Supplement: Mega-dose of vitamin A supplement
18 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
19 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
20 Recruiting Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe
Condition: Usher Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years